Guggenheim Downgrades Albireo Pharma to Neutral
Guggenheim analyst Seamus Fernandez downgrades Albireo Pharma (NASDAQ:ALBO) from Buy to Neutral.
Morgan Stanley Downgrades Air Products & Chemicals to Equal-Weight, Announces $335 Price Target
Morgan Stanley analyst Vincent Andrews downgrades Air Products & Chemicals (NYSE:APD) from Overweight to Equal-Weight and announces $335 price target.
B of A Securities Downgrades Intl Flavors & Fragrances to Underperform, Announces $121 Price Target
B of A Securities analyst Matthew DeYoe downgrades Intl Flavors & Fragrances (NYSE:IFF) from Buy to Underperform and announces $121 price target.
Cantor Fitzgerald Downgrades Cutera to Neutral, Lowers Price Target to $33
Cantor Fitzgerald analyst Louise Chen downgrades Cutera (NASDAQ:CUTR) from Overweight to Neutral and lowers the price target from $85 to $33.
Craig-Hallum Downgrades MACOM Technology Solns to Hold, Lowers Price Target to $65
Craig-Hallum analyst Richard Shannon downgrades MACOM Technology Solns (NASDAQ:MTSI) from Buy to Hold and lowers the price target from $73 to $65.
Barclays Downgrades MeridianLink to Underweight, Lowers Price Target to $14
Barclays analyst Saket Kalia downgrades MeridianLink (NYSE:MLNK) from Equal-Weight to Underweight and lowers the price target from $17 to $14.
JP Morgan Downgrades C.H. Robinson Worldwide to Neutral, Lowers Price Target to $90
JP Morgan analyst Brian Ossenbeck downgrades C.H. Robinson Worldwide (NASDAQ:CHRW) from Overweight to Neutral and lowers the price target from $103 to $90.
JP Morgan Downgrades XPO to Neutral, Lowers Price Target to $42
JP Morgan analyst Brian Ossenbeck downgrades XPO (NYSE:XPO) from Overweight to Neutral and lowers the price target from $44 to $42.
BTIG Downgrades Retail Opportunity to Neutral
BTIG analyst Michael Gorman downgrades Retail Opportunity (NASDAQ:ROIC) from Buy to Neutral.
Truist Securities Downgrades Red Rock Resorts to Hold
Truist Securities analyst Barry Jonas downgrades Red Rock Resorts (NASDAQ:RRR) from Buy to Hold.